RecruitingNot ApplicableNCT05817370

Implementation of Anal Cancer Screening and Treatment in Nigeria

Integrated Model for the Prevention of Anal Cancer Using Screen and Treat for High-grade Intraepithelial Lesions (IMPACT)


Sponsor

University of Maryland, Baltimore

Enrollment

1 participants

Start Date

May 2, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The study is a feasibility pilot trial testing 2 types of training protocols on a single physician. The first training protocol is the current standard and was developed in high-income settings. The second training protocol will be developed so tailored to the Nigerian setting. Investigators will test if the physician performs differently in their ability to conduct anal cancer screening and treatment between the 2 training protocols.


Eligibility

Inclusion Criteria5

  • Possess a medical degree in medical sciences (MBBS or equivalent)
  • At least 2-5 years of experience working with clinical HIV/AIDS community
  • Must be registered with the medical and dental council of Nigeria
  • Possess a current medical practicing license
  • Willing to work with the Sexual Gender Minority Community

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALEnhanced Training on screening and treatment of HSIL (e-STH)

Tailored training developed to overcome key barriers and promote facilitators unique to implementing HSIL screening and treatment. The development will be driven by the implementation science committee over 3 iterations every 4 months for up to a year to refine the adoption of strategies with the greatest breadth to facilitate implementation.


Locations(1)

International Center for Advocacy on Right to Health (ICARH)

Abuja, Nigeria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05817370


Related Trials